All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The aml Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the aml Hub cannot guarantee the accuracy of translated content. The aml and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The AML Hub is an independent medical education platform, sponsored by Astellas, Daiichi Sankyo, Johnson & Johnson, Kura Oncology and Syndax, and has been supported through educational grants from Bristol Myers Squibb and the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View AML content recommended for you
4th International Conference on Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment
The European School of Hematology (ESH) is a not-for-profit institution dedicated to increasing knowledge in hematology and related disciplines at the European level. The ESH Conferences are known for their state-of-the-art science and new developments in hematology.
The next conference on “Molecular and Translational advances in Biology and Treatment” is chaired by international experts in AML including two members of the AGP steering committee, Dr H. Döhner (Germany) and Dr M. Tallman (USA).
The conference will focus on the molecular techniques, which are creating novel insights into the biology and therapeutic perspectives of AML. Molecular diagnosis, genomic and epigenetic studies have allowed a better understanding of the pathobiology of the disease and identification of major pathways of malignant transformation leading to development of novel therapeutic approaches.
There will be expert panel sessions, poster sessions and a varied scientific programme. This conference promises to be a cutting-edge event in the field of hematology.
The event will take place on October 5th - 7th, 2017 in Estoril, Portugal
For more information please visit the ESH website here